| James D. Dee |
CRS |
Common Stock |
Sale |
-17.6% |
$6,190,095 |
$391.78 |
-15,800 |
73,739 |
24 Feb 2026 |
Direct |
| Steven E. Karol |
CRS |
Common Stock |
Sale |
-1.53% |
$1,333,929 |
$381.12 |
-3,500 |
225,381 |
19 Feb 2026 |
Held by Affiliates of Reporting Person |
| Steven E. Karol |
CRS |
Common Stock |
Sale |
-1.67% |
$1,140,000 |
$380.00 |
-3,000 |
177,000 |
19 Feb 2026 |
Direct |
| Charles Douglas Mclane Jr. |
CRS |
Director Stock Units |
Award |
0.34% |
|
|
85.36 |
25,106 |
31 Dec 2025 |
Direct |
| Anastasios John Hart |
CRS |
Director Stock Units |
Award |
0.18% |
|
|
38.71 |
21,904 |
31 Dec 2025 |
Direct |
| Elizabeth A. Socci |
CRS |
Common Stock |
Gift |
-4.69% |
|
|
-450 |
9,144 |
15 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Sale |
-4.98% |
$1,253,520 |
$303.52 |
-4,130 |
78,875 |
11 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Options Exercise |
5.24% |
|
|
4,130 |
83,005 |
11 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-4,130 |
0 |
11 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Sale |
-35.6% |
$13,301,026 |
$304.45 |
-43,688 |
78,875 |
10 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Options Exercise |
55.4% |
|
|
43,688 |
122,563 |
10 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-43,688 |
0 |
10 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Sale |
-26% |
$8,446,850 |
$305.60 |
-27,640 |
78,875 |
09 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Options Exercise |
40.9% |
|
|
30,942 |
106,515 |
09 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Common Stock |
Gift |
-4.18% |
|
|
-3,300 |
75,573 |
09 Dec 2025 |
Direct |
| Brian J. Malloy |
CRS |
Employee Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-30,942 |
0 |
09 Dec 2025 |
Direct |
| Elizabeth A. Socci |
CRS |
Common Stock |
Sale |
-28.9% |
$1,252,860 |
$321.25 |
-3,900 |
9,594 |
26 Nov 2025 |
Direct |
| Ramin Younessi |
CRS |
Common Stock |
Gift |
-33.4% |
|
|
-975 |
1,949 |
21 Nov 2025 |
Direct |
| Ramin Younessi |
CRS |
Common Stock |
Sale |
-30.8% |
$399,347 |
$307.19 |
-1,300 |
2,924 |
21 Nov 2025 |
Direct |
| Marshall D. Akins |
CRS |
Common Stock |
Gift |
-2.09% |
|
|
-645 |
30,159 |
18 Nov 2025 |
Direct |
| Jr. Stephen M. Ward |
CRS |
Common Stock |
Tax liability |
-1.84% |
|
|
-494 |
26,339 |
13 Oct 2025 |
Direct |
| Jr. Stephen M. Ward |
CRS |
Common Stock |
Options Exercise |
14.7% |
|
|
3,433 |
26,833 |
13 Oct 2025 |
Direct |
| Jr. Stephen M. Ward |
CRS |
Director Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-3,433 |
0 |
13 Oct 2025 |
Direct |
| Howard H. Yu |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Howard H. Yu |
CRS |
Director Stock Units |
Award |
66.7% |
|
|
557 |
1,392 |
07 Oct 2025 |
Direct |
| Ramin Younessi |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Ramin Younessi |
CRS |
Director Stock Units |
Award |
5.51% |
|
|
557 |
10,667 |
07 Oct 2025 |
Direct |
| Jr. Stephen M. Ward |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Jr. Stephen M. Ward |
CRS |
Director Stock Units |
Award |
0.73% |
|
|
557 |
77,094 |
07 Oct 2025 |
Direct |
| Colleen Pritchett |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Colleen Pritchett |
CRS |
Director Stock Units |
Award |
15.1% |
|
|
557 |
4,246 |
07 Oct 2025 |
Direct |
| Charles Douglas Mclane Jr. |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Charles Douglas Mclane Jr. |
CRS |
Director Stock Units |
Award |
2.28% |
|
|
557 |
25,005 |
07 Oct 2025 |
Direct |
| Kathleen Ligocki |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Kathleen Ligocki |
CRS |
Director Stock Units |
Award |
2.21% |
|
|
557 |
25,754 |
07 Oct 2025 |
Direct |
| Steven E. Karol |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Steven E. Karol |
CRS |
Director Stock Units |
Award |
1.38% |
|
|
557 |
41,021 |
07 Oct 2025 |
Direct |
| Anastasios John Hart |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Anastasios John Hart |
CRS |
Director Stock Units |
Award |
2.62% |
|
|
557 |
21,852 |
07 Oct 2025 |
Direct |
| Julie A. Beck |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Julie A. Beck |
CRS |
Director Stock Units |
Award |
139.7% |
|
|
557 |
956 |
07 Oct 2025 |
Direct |
| Viola L. Acoff |
CRS |
Director Stock Option (Right to Buy) |
Award |
|
|
|
304 |
304 |
07 Oct 2025 |
Direct |
| Viola L. Acoff |
CRS |
Director Stock Units |
Award |
2.63% |
|
|
557 |
21,703 |
07 Oct 2025 |
Direct |
| Anastasios John Hart |
CRS |
Director Stock Units |
Award |
0.22% |
|
|
45.82 |
21,295 |
30 Sep 2025 |
Direct |
| Charles Douglas Mclane Jr. |
CRS |
Director Stock Units |
Award |
0.42% |
|
|
102 |
24,448 |
30 Sep 2025 |
Direct |
| Steven E. Karol |
CRS |
Common Stock |
Sale |
-1.87% |
$843,773 |
$245.78 |
-3,433 |
180,000 |
09 Sep 2025 |
Direct |
| Steven E. Karol |
CRS |
Common Stock |
Options Exercise |
1.91% |
|
|
3,433 |
183,433 |
09 Sep 2025 |
Direct |
| Steven E. Karol |
CRS |
Director Stock Option (Right to Buy) |
Options Exercise |
-100% |
|
|
-3,433 |
0 |
09 Sep 2025 |
Direct |
| I. Martin Inglis |
CRS |
Common Stock |
Sale |
-45.8% |
$1,391,704 |
$244.54 |
-5,691 |
6,732 |
18 Aug 2025 |
Direct |
| I. Martin Inglis |
CRS |
Common Stock |
Options Exercise |
84.5% |
|
|
5,691 |
12,423 |
18 Aug 2025 |
Direct |